BCLI — Brainstorm Cell Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapSucker Stock

Annual balance sheet for Brainstorm Cell Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	0.569	41.9	22.1	2.98	1.3
Net Total Accounts Receivable
Net Total Receivables	2.36	0.304	0.086	0.091	0.051
Prepaid Expenses
Total Other Current Assets
Total Current Assets	3.36	43.2	23.3	3.11	1.9
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	3.14	7.99	5.97	5.32	2.1
Other Long Term Assets
Total Assets	6.53	51.3	29.3	8.45	4.21
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	17.7	11.2	6.32	8.8	7.8
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	18.8	15.8	9.94	11.5	9.07
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	-12.2	35.5	19.3	-3.02	-4.86
Total Liabilities & Shareholders' Equity	6.53	51.3	29.3	8.45	4.21
Total Common Shares Outstanding